Table 3.
Clinical and follow-up information of the AccRCC subgroup in validation cohort1
| Parameters | Disease free (n = 24) (%) | Recurrence (n = 31) (%) | Missing (n = 5) (%) |
|---|---|---|---|
| Sex | |||
| Male | 17 (71) | 26 (84) | 3 (60) |
| Female | 7 (29) | 5 (16) | 2 (40) |
| Age | |||
| 20–45 | 2 (9) | 2 (6) | 1 (20) |
| 46–59 | 8 (33) | 13 (42) | 3 (60) |
| 60–69 | 8 (33) | 12 (39) | 1 (20) |
| 70–85 | 6 (25) | 4 (13) | 0 (0) |
| WHO/ISUP | |||
| I | 1 (4) | 0 (0) | 2 (40) |
| II | 11 (46) | 8 (26) | 1 (20) |
| III | 10 (42) | 16 (52) | 1 (20) |
| IV | 2 (8) | 7 (22) | 1 (20) |
| Maximum diameter (cm) | |||
| 0–4 | 6 (25) | 5 (16) | 0 (0) |
| 4–7 | 8 (34) | 14 (45) | 4 (80) |
| 7–10 | 6 (25) | 9 (29) | 0 (0) |
| 10–15 | 4 (16) | 3 (10) | 1 (20) |
| Necrosis | |||
| Yes | 5 (21) | 18 (58) | 0 (0) |
| No | 19 (79) | 13 (42) | 5 (100) |